| Net Cash Provided by (Used in) Operating Activities |
$73,811,000 |
USD |
-62% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$923,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
450,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
134,894,155 |
shares |
0.08% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$74,734,000 |
USD |
27% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$125,566,000 |
USD |
-18% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$24,595,000 |
USD |
166% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$3,600,000 |
USD |
620% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$64,200,000 |
USD |
81% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$2,509,232,000 |
USD |
27% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$46,104,000 |
USD |
99% |
Q1 2024 |
Q1 2024 |